Control of radiation fields in breast cancer with lymphoscintigraphy.
Explore the source record for details and available documents.
Biomedical subjects
Publications and source records attributed to E Nordman.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Forty-six patients with squamous cell carcinoma of the head and neck region were randomized to either irradiation or irradiation plus bleomycin. If possible, the patients later underwent radical surgery. In the bleomycin group, significantly fewer patients had remaining tumour cells in the tissue removed at operation, and a longer time elapsed before recurrences occurred. However, bleomycin had no significant effect on the 3-and 5-year survival rates, and it did not significantly reduce the incidence of local recurrences.
45 cases of carcinoma of the stomach were treated with megavolt irradiation in the Radiotherapy Clinic of Turku University Central Hospital and in the Radiotherapy Department of the Central Hospital in Jyvâskylâ. 41 of the patients had histological or cytological verification of the tumour, 4 only an X-ray diagnosis. One-year survival of patients with local inoperable tumour was 10 out of 19, two-year survival 5 out of 19 and three-year survival 3 out of 19. Relief of symptoms was obtained in 6 cases out of 19 for one year, for two years in 4 cases out of 19, and for three years, in 3 cases. It is suggested that local inoperable carcinomas of the stomach should be treated by 5 000 rads. One-year survival of patients presenting with abdominal metastases was only 2 out of 26 and the two-year survival 1 out of 26. It appears that radiotherapy of carcinoma of the stomach, which already has metastases, is not indicated.